ALB and neoplasm: In contrast, B-22956/1 (86kDa), another contrast agent that binds reversibly to albumin, was enhanced 10 fold in the tumor rim after anti-angiogenesis therapy when compared to Gd-DTPA-albumin, and was also detected in the tumor core.